Each compound is listed with its proportion of the total vial content so you know exactly what you're working with before the calculation runs
BPC 157 can be administered in various forms, depending on the purpose
The point is, we just dont know, and there's so much more research that needs to be done
Consequently, the development of agents with high CNS bioavailability, selective target engagement, and minimal adverse effects, confirmed by well-powered, stage-stratified clinical trials, will therefore be necessary to determine their clinical utility, even though inducers and NLRP3 inhibitors continue to be promising candidates for disease-modifying therapy
Cold Spring Harb Perspect Biol [Internet]